Anti-KLH11/ KLHL11 functional antibody

Anti-KLH11/ KLHL11 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to KLHL11/KLHL11 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1621-Ab-1/ GM-Tg-hg-SE1621-Ab-2Anti-Human KLHL11 monoclonal antibodyHuman
GM-Tg-rg-SE1621-Ab-1/ GM-Tg-rg-SE1621-Ab-2Anti-Rat KLHL11 monoclonal antibodyRat
GM-Tg-mg-SE1621-Ab-1/ GM-Tg-mg-SE1621-Ab-2Anti-Mouse KLHL11 monoclonal antibodyMouse
GM-Tg-cynog-SE1621-Ab-1/ GM-Tg-cynog-SE1621-Ab-2Anti-Cynomolgus/ Rhesus macaque KLHL11 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1621-Ab-1/ GM-Tg-felg-SE1621-Ab-2Anti-Feline KLHL11 monoclonal antibodyFeline
GM-Tg-cang-SE1621-Ab-1/ GM-Tg-cang-SE1621-Ab-2Anti-Canine KLHL11 monoclonal antibodyCanine
GM-Tg-bovg-SE1621-Ab-1/ GM-Tg-bovg-SE1621-Ab-2Anti-Bovine KLHL11 monoclonal antibodyBovine
GM-Tg-equg-SE1621-Ab-1/ GM-Tg-equg-SE1621-Ab-2Anti-Equine KLHL11 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1621-Ab-1/ GM-Tg-hg-SE1621-Ab-2; GM-Tg-rg-SE1621-Ab-1/ GM-Tg-rg-SE1621-Ab-2;
GM-Tg-mg-SE1621-Ab-1/ GM-Tg-mg-SE1621-Ab-2; GM-Tg-cynog-SE1621-Ab-1/ GM-Tg-cynog-SE1621-Ab-2;
GM-Tg-felg-SE1621-Ab-1/ GM-Tg-felg-SE1621-Ab-2; GM-Tg-cang-SE1621-Ab-1/ GM-Tg-cang-SE1621-Ab-2;
GM-Tg-bovg-SE1621-Ab-1/ GM-Tg-bovg-SE1621-Ab-2; GM-Tg-equg-SE1621-Ab-1/ GM-Tg-equg-SE1621-Ab-2
Products NameAnti-KLHL11 monoclonal antibody
Formatmab
Target NameKLHL11
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KLHL11 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1621-Ag-1Recombinant multi-species KLH11/ KLHL11 protein


    Target information

    Target IDGM-SE1621
    Target NameKLHL11
    Gene ID55175,217194,287706,708393,480520,101089662,538695,100066456
    Gene Symbol and SynonymsKLHL11
    Uniprot AccessionQ9NVR0
    Uniprot Entry NameKLH11_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000178502
    Target ClassificationN/A

    The target: KLHL11, gene name: KLHL11, also named as . Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.